These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32737111)
21. Are patients with systemic lupus erythematosus at increased risk for COVID-19? Favalli EG; Gerosa M; Murgo A; Caporali R Ann Rheum Dis; 2021 Feb; 80(2):e25. PubMed ID: 32451344 [No Abstract] [Full Text] [Related]
22. Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian Mathian A; Amoura Z Ann Rheum Dis; 2022 Nov; 81(11):e217. PubMed ID: 33239273 [No Abstract] [Full Text] [Related]
23. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli Mathian A; Amoura Z Ann Rheum Dis; 2021 Feb; 80(2):e26. PubMed ID: 32451345 [No Abstract] [Full Text] [Related]
24. Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour Mathian A; Amoura Z Ann Rheum Dis; 2021 Mar; 80(3):e34. PubMed ID: 32471900 [No Abstract] [Full Text] [Related]
25. Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian Notz Q; Meybohm P; Kranke P; Weismann D; Lotz C; Schmalzing M Ann Rheum Dis; 2022 Nov; 81(11):e216. PubMed ID: 32859609 [No Abstract] [Full Text] [Related]
26. Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo Mathian A; Amoura Z Ann Rheum Dis; 2021 May; 80(5):e78. PubMed ID: 32759253 [No Abstract] [Full Text] [Related]
27. Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort. Walbi IA; Albarqi HA; Alghanim NS; Albadi MA; Al Maimouni HM; Alkahtani SA; Alshabi AM; Alali AS; Alqahtani F; Al-Najjar AH; Hazzazi MA; Alanazi DS; Sabei AA; Alsaweed OS; Alajra RK; Alqhtani H J Int Med Res; 2022 Apr; 50(4):3000605221090363. PubMed ID: 35387504 [TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine in systemic and autoimmune diseases: Where are we now? Dima A; Jurcut C; Arnaud L Joint Bone Spine; 2021 May; 88(3):105143. PubMed ID: 33515791 [TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety. Cornet A; Andersen J; Tani C; Mosca M Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33875571 [TBL] [Abstract][Full Text] [Related]
30. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998 [TBL] [Abstract][Full Text] [Related]
31. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus. Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065 [TBL] [Abstract][Full Text] [Related]
32. SLE patients are not immune to covid-19: importance of sending the right message across. Goyal M Ann Rheum Dis; 2021 Feb; 80(2):e23. PubMed ID: 32327426 [No Abstract] [Full Text] [Related]
33. Implications of SARS-CoV-2 infection for patients with rheumatic disease. Lin C; Wang Z; Li J; Xia X; Liu Y; Wang Q Ann Rheum Dis; 2022 Aug; 81(8):e152. PubMed ID: 32792333 [No Abstract] [Full Text] [Related]
34. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine. Zhang S; Liu X; Cai L; Zhang J; Zhou C Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients. Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L; Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376 [TBL] [Abstract][Full Text] [Related]
36. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Doyno C; Sobieraj DM; Baker WL Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100 [TBL] [Abstract][Full Text] [Related]
37. Clinical management of Lupus patients during the COVID-19 pandemic. Mason A; Rose E; Edwards CJ Lupus; 2020 Nov; 29(13):1661-1672. PubMed ID: 33059530 [TBL] [Abstract][Full Text] [Related]